GSK
GSK · NYSE
Bulios Fair Price
$46.93
0.9% upside
Trenutna cena
$46.51
Po podatkih Bulios Fair Price se delnica GSK trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
GSK plc is a global pharmaceutical company with a long history and a wide portfolio of medicinal products. The company specializes in researching, developing, and manufacturing drugs for various therapeutic areas, including infectious diseases, respiratory conditions, oncology, immunology, and others. GSK is known for its iconic products and vaccines that help fight diseases worldwide. The company collaborates with research institutions and partners around the world to innovate in the field of medicines and provide new and effective treatment solutions. GSK is also actively working on the development of new vaccines and drugs, including vaccines for COVID-19. GSK plc (GSK) shares may be an interesting choice for investors who follow the pharmaceutical industry and seek investment opportunities in a long-established company with innovative research and a wide portfolio of medicinal products.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Luke Victor Miels
Employees
66,841
Headquarters
London
Prihajajoči dogodki
Earnings
Upcoming earnings report